Domperidone QT risk — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Do not supply and refer for prescriber assessment
Domperidone can prolong the QT interval and is unsuitable in patients with existing QT prolongation or interacting QT-prolonging medicines. Amiodarone and citalopram make the scenario higher risk. The patient should be referred for assessment and an alternative antiemetic plan. Long-term use increases risk and is not appropriate without review.
Reference: BNF; MHRA Drug Safety Update